Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. AMWL
AMWL logo

AMWL Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
5.930
Open
5.420
VWAP
5.60
Vol
105.52K
Mkt Cap
90.37M
Low
5.300
Amount
590.54K
EV/EBITDA(TTM)
--
Total Shares
16.55M
EV
-79.75M
EV/OCF(TTM)
--
P/S(TTM)
0.35
American Well Corporation operates a hybrid care, delivery enablement platform in the United States and globally, connecting and enabling providers, payers, patients, and innovators to deliver access to more affordable quality care. It offers a single, comprehensive platform to support all digital health needs from urgent to acute and post-acute care, as well as chronic care management and healthy living. The Amwell Converge platform offers data architecture and video capabilities, flexibility and scalability, as well as a user experience focused on the needs of patients, members and providers. For health systems, its enterprise platform enables provider-to-provider virtual care for use cases ranging from stroke to virtual nursing and e-sitting. Its Amwell Carepoint devices enable healthcare providers to leverage proprietary carts and transform existing tablets and TVs into digital access points in clinical settings, helping to address personnel shortages and access limitations.
Show More

Events Timeline

(ET)
2026-02-12
16:30:00
Sees Q1 Adjusted EBITDA in Range of ($7M)-($5M)
select
2026-02-12
16:30:00
Amwell Reports Q4 Revenue of $55.3M, Exceeds Expectations
select
2026-02-12
16:30:00
Company Sees FY26 AMG Visits Between 1.32M-1.37M
select

News

Newsfilter
5.0
02-18Newsfilter
Amwell Grants 61,559 RSUs to New Employee as Inducement
  • Employee Inducement Plan: On February 18, 2026, Amwell granted 61,559 restricted stock units (RSUs) to a new employee as a significant inducement for employment, demonstrating the company's commitment to attracting and retaining talent.
  • Vesting Schedule: The RSUs will vest 25% on the first anniversary of the grant date, with the remaining 75% vesting in equal pro-rata increments every three months over three years, ensuring employee stability and long-term commitment during this period.
  • Compliance Assurance: This grant was approved by Amwell's Compensation Committee and made in reliance on the employment inducement exemption under NYSE's Listed Company Manual Rule 303A.08, ensuring the company operates within compliance frameworks.
  • Platform Advantage: Amwell offers a comprehensive technology-enabled healthcare platform aimed at providing patients with more convenient, affordable, and effective care, and as demand for online healthcare increases, the company's competitive position and influence in the market continue to grow.
seekingalpha
9.5
02-13seekingalpha
American Well Corporation Q4 2025 Earnings Call Insights
  • Strategic Transformation: American Well Corporation is undergoing a significant transformation in 2025, focusing on delivering the best tech platform in the market by divesting non-core activities and restructuring the company, which has dramatically reduced costs and set the stage for achieving cash flow breakeven in 2026.
  • Revenue Structure Optimization: The total revenue for 2025 was $249.3 million, with subscription revenue comprising 53% of total revenue, up from 45% in 2024, indicating strategic progress towards high-quality, sustainable revenue despite a 22.1% year-over-year decline in overall revenue.
  • Future Outlook: The company expects revenue in the range of $195 million to $205 million for 2026, with AMG visits projected between 1.32 million and 1.37 million, and adjusted EBITDA losses expected to decrease to between $24 million and $18 million, reflecting management's increased confidence in future cash flow.
  • Risks and Challenges: Management identified ongoing risks such as continued churn and the need to renew the DHA contract, although proactive measures in maintaining high renewal rates and transitioning to a single platform are being implemented to address challenges posed by emerging AI competitors.
seekingalpha
9.5
02-12seekingalpha
American Well Releases 2026 Financial Guidance with Q4 Results
  • Earnings Beat: American Well's Q4 GAAP EPS of -$1.52 exceeded expectations by $0.26, despite a revenue drop of 22.1% year-over-year to $55.31 million, which still beat estimates by $2.6 million, showcasing the company's resilience in challenging conditions.
  • 2026 Financial Outlook: The company projects 2026 revenue between $195 million and $205 million, with AMG visits expected between 1.32 million and 1.37 million, and adjusted EBITDA ranging from -$24 million to -$18 million, reflecting cautious optimism for future growth.
  • Q1 2026 Guidance: American Well anticipates Q1 2026 revenue between $48 million and $53 million, with adjusted EBITDA projected between -$7 million and -$5 million, indicating ongoing short-term challenges but potential for gradual improvement.
  • Positive Market Reaction: Despite the overall revenue decline, the market reacted positively to the company's earnings beat and future guidance, which may boost investor confidence and improve stock performance.
seekingalpha
9.5
02-11seekingalpha
American Well to Announce Q4 Earnings on February 12
  • Earnings Announcement Date: American Well is set to release its Q4 earnings on February 12 after market close, with heightened investor interest due to the accelerated digital transformation in the healthcare sector.
  • Expected Financial Performance: Analysts forecast an EPS of -$1.59, indicating challenges in profitability that could affect investor confidence and lead to stock price volatility.
  • Revenue Decline Forecast: The anticipated revenue of $52.71 million represents a 25.8% year-over-year decline, reflecting pressures from intensified market competition and shifting customer demands, which may impact future growth strategies.
  • Historical Financial Data: Historical earnings data for American Well shows that despite current challenges, the company has demonstrated resilience over the past few quarters, prompting investors to consider its long-term growth potential.
Yahoo Finance
7.0
02-10Yahoo Finance
Hims & Hers Drops 16% Amid Novo Nordisk Lawsuit
  • Significant Stock Decline: Hims & Hers Health closed at $19.33 on Monday, down 16.03%, reflecting market concerns over legal risks, particularly following the lawsuit filed by Novo Nordisk.
  • Surge in Trading Volume: The company experienced a trading volume of 143.5 million shares, which is 688% above its three-month average of 18.2 million shares, indicating heightened investor anxiety regarding its future.
  • Increased Legal Pressure: The lawsuit from Novo Nordisk seeks to prevent Hims & Hers from selling compounded versions of its patented drugs, intensifying the legal and regulatory challenges the company faces, which could impact its market strategy.
  • Negative Market Reaction: Hims & Hers has seen a cumulative decline of 26.89% over the past five days, suggesting a waning investor confidence in its business transformation, especially after the announcement to withdraw its copycat obesity drug Wegovy.
NASDAQ.COM
9.5
2025-11-05NASDAQ.COM
American Well (AMWL) Q3 Earnings: Analyzing Key Metrics Against Estimates
  • Quarterly Revenue and EPS: American Well Corporation (AMWL) reported $56.29 million in revenue for Q3 2025, a 7.8% decline year-over-year, with an EPS of -$1.74 compared to -$2.87 a year ago.

  • Surprise Metrics: The revenue exceeded the Zacks Consensus Estimate by 3.53%, while the EPS also surpassed expectations by 4.92%.

  • Investor Insights: Investors are advised to focus on key metrics that provide deeper insights into the company's performance, beyond just headline revenue and earnings figures.

  • Research Recommendations: Zacks Investment Research offers insights and recommendations, including a report on the "7 Best Stocks for the Next 30 Days."

Wall Street analysts forecast AMWL stock price to rise
4 Analyst Rating
Wall Street analysts forecast AMWL stock price to rise
0 Buy
4 Hold
0 Sell
Hold
Current: 0.000
sliders
Low
6.00
Averages
6.00
High
6.00
Current: 0.000
sliders
Low
6.00
Averages
6.00
High
6.00
Stifel
David Grossman
Hold
downgrade
$6 -> $5
AI Analysis
2026-02-13
Reason
Stifel
David Grossman
Price Target
$6 -> $5
AI Analysis
2026-02-13
downgrade
Hold
Reason
Stifel analyst David Grossman lowered the firm's price target on Amwell to $5 from $6 and keeps a Hold rating on the shares. 2026 revenue guidance coming in about $40M below consensus reflects strategic portfolio restructuring, exiting lower-quality revenue streams, and client-specific contract adjustments, the analyst tells investors in a post-earnings note.
TD Cowen
Charles Rhyee
Hold
downgrade
$7 -> $5
2026-02-13
Reason
TD Cowen
Charles Rhyee
Price Target
$7 -> $5
2026-02-13
downgrade
Hold
Reason
TD Cowen analyst Charles Rhyee lowered the firm's price target on Amwell to $5 from $7 and keeps a Hold rating on the shares. The firm said Q4 EBITDA was a solid beat andd reaffirming EBITDA for 2026 is encouraging but the 20% revenue decline guidance is concerning.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for AMWL
Unlock Now

Valuation Metrics

The current forward P/E ratio for American Well Corp (AMWL.N) is -0.88, compared to its 5-year average forward P/E of -10.78. For a more detailed relative valuation and DCF analysis to assess American Well Corp's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-10.78
Current PE
-0.88
Overvalued PE
13.57
Undervalued PE
-35.13

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-2.18
Current EV/EBITDA
2.88
Overvalued EV/EBITDA
3.37
Undervalued EV/EBITDA
-7.73

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
3.19
Current PS
0.35
Overvalued PS
6.96
Undervalued PS
-0.58

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

best trades for daytrading today
Intellectia · 11 candidates
Volume: 0 - 10,000,000,000Price Change Pct: $1.50 - $100.00Relative Vol: 1.50 - 100List Exchange: XNYSSupport Resistance Relationship: PriceBreakResistance, PriceFallBelowSupportThree Min Rate Of Change: 0.3% - 100.0%
Ticker
Name
Market Cap$
top bottom
LMND logo
LMND
Lemonade Inc
3.94B
EXK logo
EXK
Endeavour Silver Corp
3.89B
AMWL logo
AMWL
American Well Corp
89.88M
HL logo
HL
Hecla Mining Co
15.63B
PSQH logo
PSQH
PSQ Holdings Inc
32.85M
FDS logo
FDS
Factset Research Systems Inc
7.67B
What stocks are about to reverse trend
Intellectia · 14 candidates
Price: $3.00 - $100.00Moving Average Relationship: PriceCrossAboveMA20Month Price Change Pct: >= $0.00Support Resistance Relationship: PriceBreakResistanceMonthly Average Dollar Volume: >= 300,000
Ticker
Name
Market Cap$
top bottom
MLEC logo
MLEC
Moolec Science SA
6.27M
ATOM logo
ATOM
Atomera Inc
126.83M
FGL logo
FGL
Founder Group Ltd
7.47M
CRSR logo
CRSR
Corsair Gaming Inc
723.65M
AMWL logo
AMWL
American Well Corp
89.38M
LGCY logo
LGCY
Legacy Education Inc
145.68M
inom den amerikanska marknaden
Intellectia · 15 candidates
Market Cap: <= 1.50BPrice: <= $25.00Beta: HighRiskRsi 14: <= 45Month Price Change Pct: >= $0.00
Ticker
Name
Market Cap$
top bottom
SG logo
SG
Sweetgreen Inc
820.33M
NVX logo
NVX
NOVONIX Ltd
222.62M
LFMD logo
LFMD
LifeMD Inc
170.40M
TMCI logo
TMCI
Treace Medical Concepts Inc
166.30M
HFFG logo
HFFG
Hf Foods Group Inc
116.17M
PYXS logo
PYXS
Pyxis Oncology Inc
103.36M

Whales Holding AMWL

S
Senvest Management, LLC
Holding
AMWL
-4.12%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is American Well Corp (AMWL) stock price today?

The current price of AMWL is 5.56 USD — it has increased 1.83

What is American Well Corp (AMWL)'s business?

American Well Corporation operates a hybrid care, delivery enablement platform in the United States and globally, connecting and enabling providers, payers, patients, and innovators to deliver access to more affordable quality care. It offers a single, comprehensive platform to support all digital health needs from urgent to acute and post-acute care, as well as chronic care management and healthy living. The Amwell Converge platform offers data architecture and video capabilities, flexibility and scalability, as well as a user experience focused on the needs of patients, members and providers. For health systems, its enterprise platform enables provider-to-provider virtual care for use cases ranging from stroke to virtual nursing and e-sitting. Its Amwell Carepoint devices enable healthcare providers to leverage proprietary carts and transform existing tablets and TVs into digital access points in clinical settings, helping to address personnel shortages and access limitations.

What is the price predicton of AMWL Stock?

Wall Street analysts forecast AMWL stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AMWL is6.00 USD with a low forecast of 6.00 USD and a high forecast of 6.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is American Well Corp (AMWL)'s revenue for the last quarter?

American Well Corp revenue for the last quarter amounts to 55.31M USD, decreased -22.11

What is American Well Corp (AMWL)'s earnings per share (EPS) for the last quarter?

American Well Corp. EPS for the last quarter amounts to -1.52 USD, decreased -45.13

How many employees does American Well Corp (AMWL). have?

American Well Corp (AMWL) has 562 emplpoyees as of March 09 2026.

What is American Well Corp (AMWL) market cap?

Today AMWL has the market capitalization of 90.37M USD.